Journal
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Volume 26, Issue 1, Pages 74-85Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.urolonc.2007.03.017
Keywords
cancer therapy; cancer diagnosis; nanocarriers; targeting molecules
Categories
Funding
- NATIONAL CANCER INSTITUTE [U54CA119349] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K08EB003647] Funding Source: NIH RePORTER
- NCI NIH HHS [CA119349] Funding Source: Medline
- NIBIB NIH HHS [EB003647] Funding Source: Medline
Ask authors/readers for more resources
Nanotechnology is a field of research at the crossroads of biology, chemistry, physics, engineering, and medicine. Design of multifunctional nanoparticles capable of targeting cancer cells, delivering and releasing drugs in a regulated manner, and detecting cancer cells with enormous specificity and sensitivity are just some examples of the potential application of nanotechnology to oncological diseases. In this review we discuss the recent advances of cancer nanotechnology with particular attention to nanoparticle systems that are in clinical practice or in various stages of development for cancer imaging and therapy. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
